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Hypertension is a multifactorial disorder considered one of the major causes of premature death worldwide. This pathology is
associated with vascular functional/structural alterations in which nitric oxide (NO) and oxygen reactive species participate. On
the other hand, the use of microalgae extracts in the treatment of cardiovascular diseases is increasing. Based on the antioxidant
and antihypertensive properties of Spirulina, this study aims to investigate the effect of an aqueous extract of Spirulina on the
vasodilator function of the aorta from spontaneously hypertensive rats (SHR), analyzing the functional role of NO. For this,
aortic segments from male SHR were divided into two groups, one control and the other exposed to an Spirulina aqueous
extract (0.1% w/v, for 3 hours), to analyze (i) the production of NO, superoxide anion, and hydrogen peroxide; (ii) the
vasodilator response induced by acetylcholine (ACh), by the NO donor and sodium nitroprusside (SNP), and by the KATP
channel opener and pinacidil; and (iii) the expression of the p-Akt, p-eNOS, and HO-1 proteins. The results showed that the
aqueous Spirulina extract (i) increased the production of NO, did not significantly modify that of superoxide, while decreased
that of hydrogen peroxide; (ii) increased the vasodilatory responses induced by ACh, NPS, and pinacidil; and (iii) increased the
expression of p-Akt and HO-1. These results suggest that incubation with the aqueous Spirulina extract improves the vascular
function of arteries from SHR by increasing the release/bioavailability/function of NO. Increased KATP channel activation and
expression of pAkt and HO-1 appear to be participating in these actions.
1. Introduction
Cardiovascular diseases represent the most common cause of
death worldwide, and hypertension is one of the main risk
factors for its development. This pathology is associated with
vascular remodeling [1] that may be caused by an imbalance
in the production and function of endothelial factors [2]
which leads to increased vascular resistance. Among endo-
thelial factors, nitric oxide (NO) plays a crucial role in vascu-
lar tone regulation through its vasodilator, antiproliferative,
and antiaggregant actions [3]. It is well known that NO-
induced vasodilation is mediated by increasing cyclic guano-
sine monophosphate (cGMP) levels and cGMP-dependent
protein kinase (PKG) activation in vascular smooth muscles
[4]. Likewise, NO, cGMP, and PKG are able to activate potas-
sium channels and hyperpolarize the cell membrane [5, 6].
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Thus, potassium channels are widely expressed in vascular
tissue, and their role in vessel tone regulation has been well
established [7]. The participation of hyperpolarizing mecha-
nisms has gained relevance in physiopathological conditions
matching with decreased NO bioavailability through the acti-
vation of calcium- and ATP-dependent potassium (KCa or
KATP, respectively) channels [8, 9]. In this regard, decreased
NO bioavailability usually links to the increased production
of reactive oxygen species (ROS), the latter being another
hallmark of cardiovascular diseases including hypertension
[10]. However, under pathophysiological conditions with
increased oxidative stress, different homeostatic mechanisms
can be activated. Thus, nuclear factor erythroid 2-related fac-
tor 2 (Nrf2) mediates the transcription of phase II antioxi-
dant proteins responsible for the elimination of ROS [11].
Among the different target proteins of Nrf2, it should be
noted that hemeoxygenase-1 (HO-1) has been recognized
as one of the most important factors protecting vascular tis-
sue from a prooxidant environment [12, 13].
In addition to the antihypertensive classical pharmaco-
logical therapy [14, 15], the consumption of natural com-
pounds is increasing nowadays [16–19]. Recently,
increasing attention has been paid to the use of microalgae
since they contain various valuable natural compounds that
have uses in the pharmaceutical, cosmetic, and nutraceutical
industries [20, 21]. Among the microalgae, the filamentous
cyanobacterium of the genus Arthrospira (e.g., A. platensis,
A. maxima), commercially named as Spirulina, is referred
to as a “superfood” with antioxidant-antihypertensive activi-
ties, cholesterol-controlling, and insulin resistance effects
[22, 23]. Based on this information, the objective of this study
was to analyze the effect of aqueous Spirulina extract on the
vasodilator function of the aorta from spontaneously hyper-
tensive rats (SHR) investigating the contribution of NO. Cell
mediators (superoxide anion and hydrogen peroxide) and
phosphorylation and/or expression of signalling proteins
(eNOS, Akt, and HO-1) related to the production and/or bio-
availability of NO were also studied.
2. Materials and Methods
2.1. Animals and Vascular Tissue Preparation. Male SHR
rats, 5 months old, were selected by crossing Wistar-Kyoto
rats with constitutive high blood pressure in the Animal
Facility of the Universidad Autónoma de Madrid (UAM)
(registration number EX-021U). All animal protocols were
approved by the Research Ethics Committee of UAM accord-
ing to directives 609/86 CEE and R.D. 233/88 of the Minis-
terio de Agricultura, Pesca y Alimentación of Spain
(PROEX 202/16). The experiments were conducted in accor-
dance with the published Guiding Principles in the Care and
Use of Animals approved by the European Union directives
63/2010 UE and Spanish regulation RD53/2013. Systolic
blood pressure was indirectly measured in awake animals
by the tail-cuff method (Letica, Digital Pressure Meter,
LE5000, Barcelona, Spain) before sacrifice. Rats were sacri-
ficed by CO2 inhalation and subsequent decapitation; the
aorta was carefully dissected out and placed in Krebs-
Henseleit solution (KHS) at 4°C containing 115mM NaCl,
2.5mM CaCl2, 4.6mM KCl, 1.2mM KH2PO4, 1.2mM
MgSO4, 25mM NaHCO3, and 11.1mM glucose. The aorta,
from SHR, was cleaned of adhering adipose and connective
tissues, cut into rings of 4mm in length, and divided into
two groups according to the presence or absence of Spirulina:
arteries exposed for 3 h to the aqueous Spirulina extract
(0.1% w/v) and arteries incubated in KHS medium in which
Spirulina was dissolved (control group) except for the exper-
iments of NO release where the Spirulina extract was dis-
solved in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer containing 119mM NaCl, 20mM
HEPES, 1.2mM CaCl2, 4.6mM KCl, 0.4mM KH2PO4,
1mM MgSO4, 5mM NaHCO3, 5.5mM glucose, and
0.15mM Na2H2PO4.
2.2. Aqueous Extract of Spirulina. To obtain the Spirulina
biomass, the Arthrospira platensis BIO1 strain, kindly sup-
plied by Biodesma S.L., was used. A. platensis was grown in
plastic bioreactors in a greenhouse at the Universidad Poli-
técnica de Madrid (40.446353 N-3.738341 E), as previously
described [24, 25]. Briefly, A. platensis was harvested when
the culture reached approximately 1 g/L of dry weight. The
harvest was performed from 9:00 to 10:30 hours when the
protein content was higher [26]. Then, the cells were dried
on a horizontal sheet at 50°C for approximately 4-6 h and
kept in an opaque container at 4°C to prevent oxidation.
A polar Spirulina extract was prepared by solvent extrac-
tion according to the Bligh and Dyer method [27] after a
prior step of Spirulina biomass sonication. Briefly, 50mg of
Spirulina biomass suspended in 1mL of chlorophorm/-
methanol 1 : 2 (v/v) was submitted to 40 kHz sonication for
15min at 25°C. The liquid phase was filtrated, and the recov-
ered biomass was extracted with 0.5mL of chlorophorm/-
methanol 1 : 2 (v/v). Next, the polar Spirulina
biocomponents were separated by adding twice 0.6mL of
water with 0.58% NaCl to the chlorophorm/methanol phase.
After gravimetric separation of phases for 24h at 4°C, the
aqueous phase was dried in a Buchi B480 rotary evaporator,
weighed, and frozen at -70°C until use.
2.3. Vascular Reactivity. The method used for isometric ten-
sion recording has been described in full elsewhere [28].
Briefly, aortic segments were suspended in an organ bath
containing 5mL of KHS at 37°C, continuously bubbled with
95% O2-5% CO2 mixtures (pH7.4). Two parallel stainless
steel pins were introduced through the lumen of the vascular
segment: one fixed to the bath wall and the other connected
to a force transducer (Grass FTO3C; Grass Instruments
Co., Quincy, MA, USA); this in turn was connected to a
model 7D Grass polygraph. The aortic segments were sub-
jected to a tension of 1 g which was readjusted every 15min
during a 90min equilibration period before drug administra-
tion. After this, the vessels were exposed to 75mM KCl to
check the functional integrity. After a washout period, the
viability of vascular endothelium was tested by the ability of
10μM ACh to relax precontracted segments with 0.1μM
NA. Vessels were then washed with KHS to recover the basal
tension. To investigate the effect of the aqueous Spirulina
extract on the vasodilator response, separate aortic segments
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from SHR were incubated with the Spirulina extract (0.1%
w/v) for 3 h (with changes every hour) before performing
cumulative concentration-response curves to 0.1 nM-10μM
ACh, to the NO donor 0.1 nM-10μM sodium nitroprusside
(SNP), and to the KATP channel opener 0.1μM-10μM pina-
cidil in 0.1μM NA precontracted rings.
2.4. Release of Nitric Oxide. The release of NO was measured
by using the fluorescent probe 4,5-diaminofluorescein (DAF-
2, at 0.5μM) as previously reported [29, 30]. The fluores-
cence of the medium was measured at room temperature
using a luminescence spectrometer LS50 (Perkin-Elmer
Instruments) with the excitation wavelength set at 495 nm
and emission wavelength at 515nm. Also, blank measures
were collected in the same way from the medium without
mesenteric segments to subtract background emission.
2.5. Detection of Superoxide Anion.Hydroethidine, an oxida-
tive fluorescent probe, was used to evaluate superoxide anion
levels in situ, as previously described [29, 31, 32]. The tissue
was also stained with the nuclear dye 4′,6-diamidino-2-phe-
nylindole (DAPI, 10μg/mL). Segments were mounted on
glad slides and imaged on a confocal microscope. Images
were obtained with a LEICA (TCS ST2 DM IRE2) laser scan-
ning confocal microscope to detect nuclei (405nm excitation
and 410-475 nm emission, for the DAPI dye) and oxidized
hydroethidine (excitation 488nm, emission 610nm). Laser
and image settings were unchanged for the acquisition of
images from the three groups of rats. The photomicrographs
show the intensity and location of hydroethidine, which
reflects superoxide production, so that a comparison of these
groups could be made. To analyze fluorescence intensity, the
ImageJ Analysis Software (National Institutes of Health) was
used. The amount of superoxide formation was expressed as
the ratio between the fluorescence emitted by hydroethidine
and that emitted by DAPI.
2.6. Production of Hydrogen Peroxide. The formation of
hydrogen peroxide in aortic rings was measured by using a
fluorescence H2O2 assay kit (Cayman Chemical) as previ-
ously reported [32]. Some assays were performed in the pres-
ence of catalase, an H2O2 scavenger, to ensure the specificity
of the method. The fluorescence at 530 and 590 nm excitation
and emission wavelengths, respectively, was registered in a
96-microplate reader (Multiskan Ascent, Labsystems). The
protein content in the aortic samples was quantified by the
bicinchoninic acid assay using the BCA™ Protein Assay Kit
(Pierce). Data were expressed as nanomole per microgram
of protein.
2.7. Western Blot Analysis of p-Akt, p-eNOS, and HO-1
Expression. Arterial segments were homogenated and proc-
essed to quantify protein concentration at 4°C in RIPA buffer
containing phosphatase inhibitors and a cocktail of protease
inhibitors. Proteins (20μg) were separated by SDS-PAGE
gels and transferred to polyvinylidene difluoride (PVDF)
membranes (Bio-Rad Immun-Blot® overnight at 4°C,
230mA, using a Bio-Rad Mini Protean III system (Bio-Rad
Laboratories, Hercules, CA, USA). Membranes were blocked
with 5% (w/v) fat-free powdered milk or 5% (w/v) bovine
serum albumin following the instructions of the antibodies’
manufacturers and incubated overnight with mouse mono-
clonal antibody for phospho-eNOS (1:250dilution), pur-
chased from Transduction Laboratories (Lexington, UK),
anti-phospho-Akt (S473), or with rabbit polyclonal antibody
for HO-1 (1 : 2000 dilution), purchased from Stresggen Bior-
eagents (Victoria, Canada). After washing, the membrane
was incubated with the corresponding anti-
immunoglobulin G conjugated to horseradish peroxidase
(Amersham International Plc). The membrane was thor-
oughly washed, and the immunocomplexes were detected
using an enhanced horseradish peroxidase/luminol chemilu-
minescence system (ECL Plus, Amersham International Plc,


































ANOVA: p < 0.0001
Figure 1: Effect of the aqueous Spirulina extract incubation on the concentration-response curve to acetylcholine in aortic segments, with
different amounts of functional endothelium, from SHR. Results (means ± SEM) are represented as the percentage of inhibition of the
contraction elicited by 0.1μM noradrenaline. Number of animals: 5-7. The statistical significance is indicated in the corresponding graphs.
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(Hyperfilm ECL, Amersham International Plc). Signals on
the immunoblot were quantified using a computer program
(NIH Image V1.56). The same membrane was used to deter-
mine GAPDH expression, and the content of the latter was
used to correct p-AKt, p-eNOS, and HO-1 expression in each
sample, by means of a monoclonal antibody anti-GAPDH
(1 : 5000 dilution, Sigma).
2.8. Data Analysis. Results are given as mean ± SEM (Stan-
dard Error of the Mean). The relaxation induced by ACh,
SNP, or pinacidil was expressed as a percentage of initial con-
traction elicited by NA. Statistical analysis was performed by
comparing the curves obtained in aortae from SHR rats after
Spirulina extract incubation with that obtained in the
absence of the extract by means of two-way analysis of vari-
ance (ANOVA). For NO, superoxide anion and hydrogen
peroxide production and proteins expression statistical anal-
ysis was done using Student’s t-test for unpaired experi-
ments. A p value of less than 0.05 was considered
significant. The statistical analysis and the elaboration of
the graphs were carried out using the statistical program
GraphPad PRISM® (Version 6.01).
2.9. Drugs and Chemicals. The drugs used were as follows:
DAF-2, HE, L-NA hydrochloride, ACh chloride, potassium
chloride, SNP, and pinacidil (Sigma-Aldrich). The stock
solutions (10mM) of drugs were prepared in distilled water,
except for NA which was dissolved in NaCl (0.9%)-ascorbic
acid (0.01% w/v) solution. These solutions were kept at
-20°C, and appropriate dilutions were made in KHS on the
day of the experiment.
3. Results
3.1. Animal Weight and Systolic Blood Pressure. The body
weight (315 ± 9:5 g) and systolic blood pressure of the SHR
(162 ± 4:7mmHg) were similar to those reported in previous
studies [33–35].
3.2. Vascular Reactivity. In NA-precontracted arterial seg-
ments, the vasodilator response induced by ACh (0.1 nM-
10μM) was increased after Spirulina extract incubation
(Figure 1). A detailed analysis showed that the Spirulina-
induced increase of the vasodilatory action of Ach was
greater in vessels with less than 30% of endothelium than in
those with above 60% endothelium (Figures 1(a), 1(b)).
To analyze the possible action of Spirulina on the sensi-
tivity of smooth muscle cells to NO, the vasodilator response
induced by the NO donor, SNP, was studied. After incuba-
tion with Spirulina extract, the vasodilator response elicited
by SNP (0.1 nM-10μM) was increased (Figure 2).
Due to the involvement of KATP in the vasodilator
responses, the effect of the Spirulina extract on the function
















ANOVA: p < 0.0001
Control
Spirulina
Figure 2: Effect of the aqueous Spirulina extract incubation on the
concentration-response curve to the NO donor sodium
nitroprusside in aortic segments from SHR. Results (means ± SEM
) are presented as a percentage of inhibition of the contraction
elicited by 0.1 μM noradrenaline. Number of animals: 5-7. The














ANOVA: p < 0.0001
Control
Spirulina
Figure 3: Effect of the aqueous Spirulina extract incubation on the
concentration-response curve to the KATP channel opener
pinacidil in aortic segments from SHR. Results (means ± SEM) are
represented as the percentage of inhibition of the contraction
elicited by 0.1 μM noradrenaline. Number of animals: 5-7. The























Figure 4: Effect of the aqueous Spirulina extract incubation on the
basal release of NO in aortic segments from SHR. Results
(means ± SEM) are expressed as arbitrary units of fluorescence
(AU) per milligram of tissue. Number of animals: 5-7. ∗p < 0:05
compared with the control condition (in the absence of Spirulina
extract).
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of the KATP channels was analyzed. Concentration-response
curves to the KATP channel opener pinacidil (0.1μM-
10μM) were analyzed in 0.1μM NA precontracted aortic
rings from SHR ± Spirulina extract. The results showed that
the vasodilator response to pinacidil was enhanced after
incubation with Spirulina extract (Figure 3).
3.3. NO Release. After incubation with 4,5-diaminofluores-
cein, the fluorescence emitted was higher in arteries exposed
to the aqueous extract of Spirulina with respect to the control
condition (Figure 4).
3.4. Detection of Superoxide Anion. In arteries from SHR, the
incubation with Spirulina extract did not significantly modify
the production of superoxide anion (Figure 5). The Spirulina
extract did not modify the fluorescence emitted by DAPI.
3.5. Detection of Hydrogen Peroxide. In aortae from SHR, the
incubation with the Spirulina extract reduced the levels of
hydrogen peroxide (Figure 6).
3.6. Expression of p-eNOS, p-Akt, and HO-1. The effect of Spi-
rulina extract on the expression of p-Akt, p-eNOS, and HO-1
was analyzed in homogenates of aortae from SHR by using
western blot analysis. The results show that the expression
of p-Akt and HO-1 were increased, while that of p-eNOS
was not statistically modified after Spirulina incubation
(Figure 7).
4. Discussion
Overall, the present work shows that incubation with the
aqueous extract of Spirulina improves the vasodilator
response in arteries from hypertensive rats. Additionally,
the increase in the NO release/bioavailability and in the activ-
ity of potassium channels seem to be mechanisms involved in
the Spirulina-induced effect.
Hypertension has been described to compromise the
vasodilator function by altering the release/function of vaso-
dilator factors, among which NO and ROS are relevant
players. Based on previous observations, the effect of the
aqueous extract of Spirulina on the ACh-induced vasodila-
tion was analyzed in arteries from SHR rats with different
amounts of functional endothelium. The results show that
in the aorta with functional endothelium above 60%, the Spi-
rulina extract induced lesser increase in the ACh-induced
response than in arteries with functional endothelium below
30%. These results indicate that aqueous Spirulina extract
seems to act through endothelial-dependent and
endothelial-independent mechanisms. Regarding
endothelial-dependent mechanisms, one plausible mecha-
nism would be increased NO release. Our results show that
the release of NO was increased in arteries from SHR, as in
previous studies [36, 37]. Additionally, since increased pro-
duction of contractile prostanoids has been reported in
hypertension [38], so the greater effect exerted by Spirulina
could also be due to the decrease in the contractile factors
as the endothelium is removed. However, the participation
of mediators other than NO in the Spirulina-induced effect
cannot be ruled out and will require further investigation.
Once the NO released was determined, the following step
was to analyze the possible modification that Spirulina
extract could exert on the sensitivity of the smooth muscle
to the NO. The results show that the SNP-induced response



































Figure 5: Effect of the aqueous Spirulina extract incubation on the production of superoxide anion in aortic segments from SHR.
Representative confocal images showing in situ detection of superoxide anion in red and DAPI-nuclei staining in blue. Quantitative
analysis of fluorescence is also shown. Results (means ± SEM) are expressed as the ratio between the fluorescence emitted by























Figure 6: Effect of the aqueous Spirulina extract incubation on the
production of hydrogen peroxide in aortic segments from SHR.
Results (means ± SEM) are expressed as nanomoles of H2O2 per
microgram of protein. Number of animals: 5. ∗p < 0:01 compared
with the control condition (in absence of Spirulina extract).
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with studies describing an increased participation of NO in
the responses induced by a different agonist after Spirulina
treatment [36, 37]. Additionally, it is important to note that
the greatest increment observed in the SNP-induced relaxa-
tion after Spirulina extract incubation was observed at low
concentrations of SNP, which may be considered of physio-
logical relevance. Although there is no specific information
on the effect of Spirulina extract on the NO donor-induced
vasodilation, the results described here indicate that Spiru-
lina may also act through endothelium-independent
mechanisms.
Taking into account that NO can hyperpolarize cell
membranes by activating potassium channels and that
changes in the activity of KATP channels have been impli-
cated in the development of hypertension [39, 40], the vaso-
dilator response to the KATP channel opener pinacidil was
investigated. The results show that the pinacidil-induced
relaxation was increased by the incubation with the aqueous
Spirulina extract, which suggests that Spirulina extract could
increase the activity of KATP channels. To date, the activation
of potassium channels by Spirulina water-soluble compo-
nents has not been reported, but it could be a plausible
hypothesis as occurs with lipophilic components such as
polyunsaturated fatty acids that are able to activate potas-
sium channels [32, 41, 42]. The fact that the greatest effect
was again observed at low concentrations of pinacidil points
out the physiological relevance of Spirulina extract exposure,
since the same profile in the effect of the aqueous extract on
the three tested vasodilator responses was observed.
Interestingly, it has been reported that opening KATP
channels increase the expression of p-Akt [43]. Since p-AKt
is involved in the activation of eNOS, the expression of both
proteins was also analyzed; the results showed that Spirulina
extract increased the expression of p-Akt which can be
responsible for the increased production of NO. However,
Spirulina extract failed to significantly increase the expres-
sion of p-eNOS which suggests an increase of eNOS activity
and/or a decrease of NO metabolism that would match with
the increased NO release observed after incubating vessels
with the Spirulina extract. Since the antioxidant property of
Spirulina has been reported, an increase in the NO bioavail-
ability cannot be ruled out. In this regard, it is important to
note that in response to prooxidant environments, as occurs
in hypertension, HO-1 is one of the earliest expressed pro-
teins and its involvement in cardiovascular protection has
been described [12, 13]. The fact that the Spirulina extract
increases the expression of HO-1 would be in agreement with
the antioxidant properties of the cyanobacteria, as has been
described in glial cells [44]. Additionally, several investiga-
tions have reported that the increased expression of HO-1
induced by different natural products is mediated through
p-AKt [45–48]. Therefore, the next step was to analyze the
influence of the Spirulina extract on the formation of super-
oxide anion. The results, contrary to what was expected,
show no statistical differences in the production of superox-
ide anion after incubation with the Spirulina extract. This
result apparently disagrees with most of the studies describ-
ing an antioxidant effect of Spirulina [49–51]. One possible
explanation is that higher concentration and/or incubation
time of Spirulina was required to diminish the overproduc-
tion of superoxide, either by modulating NADPH oxidase
and/or SOD activity. Interestingly, the choice of the cyano-
bacteria strain is also important, since differences in the syn-
thesis of bioactive compounds, even in smaller quantities,
may have an impact on health-promoting properties [52].
Another possibility could be that SOD was already activated
as a compensatory mechanism in an attempt to eliminate the
elevated superoxide production reported in different physio-
pathological conditions such as hypertension [53], athero-
sclerosis [54], and/or aging [55] and that the Spirulina
extract could not induce further activation. Therefore, the
content of hydrogen peroxide was analyzed, showing that
the incubation with the Spirulina extract decreased the pro-
duction of this particular ROS. This result agrees with most
of the studies describing the general antioxidant properties
of Spirulina [36, 37]. There are still remaining important
questions about the differences between the properties of
the isolated Spirulina extracts and the properties exerted on
specific biological tissues, depending also on the particular




































































Figure 7: Representative western blot and densitometric analysis for the expression of p-Akt, p-eNOS, and HO-1 protein in aortic segments
from SHR in the absence (control) or in the presence of the aqueous Spirulina extract. Results (means ± SEM) are expressed as the ratio
between the signal for p-Akt, p-eNOS, or HO-1 protein and the signal for GAPDH. Number of animals: 3-5. ∗p < 0:01 compared with the
control condition (in the absence of Spirulina extract).
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considerations ensure future studies paying special attention
to the Spirulina extract diet supplementation, since these
experiments could report any potential improvement in dif-
ferent biochemical, cellular, and physiological parameters
directly related to the maintenance of a healthy vascular
function.
5. Conclusion
In summary, the current study describes some of the possible
mechanisms involved in the effects induced by the Spirulina
extract, paying special attention to the functional role of
NO. Incubation with an aqueous Spirulina extract improved
the vasodilator response of the aorta from hypertensive rats
through the increased NO release/bioavailability and func-
tion, linked to the increased expression of p-Akt and HO-1.
Also, the activation of KATP channels was involved in that
effect.
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